PCM
SRTA

Polymer Capital Management’s Strata Critical Medical Inc SRTA Stock Holding History

Polymer Capital Management’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.2K Buy
+12,747
New +$67.1K 0.01% 596

Other funds holding SRTA

TP
Third Point New York $4.68B AUM 37.3% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $337M AUM 63.03% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $366M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polymer Capital Management's SRTA Position: Q2 2026 in Review

Polymer Capital Management opened a new position in Strata Critical Medical Inc (SRTA) in Q2 2026: 12,747 shares worth $67.2K. The stake represents 0.01% of the portfolio and ranks #596 among its holdings.

139 funds tracked by Wall St. Rank hold SRTA as of Q2 2026.

  • Polymer Capital Management held 12,747 shares of Strata Critical Medical Inc worth $67.2K as of Q2 2026.
  • Strata Critical Medical Inc was a new Polymer Capital Management position in Q2 2026.
  • Strata Critical Medical Inc made up 0.01% of Polymer Capital Management's portfolio in Q2 2026, its #596 holding.
  • 139 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q2 2026.

Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.